Skip to main navigation

Skip to content

Newsroom
Join our team

About us
Our purpose
Our culture
Products & pipeline
Investors

About us
Our purpose
Our culture
Products & pipeline
Investors

Newsroom
Join our team

About us
Our purpose
Our culture
Products & pipeline
Investors

Newsroom
Join our team

Dashboard
Press releases
Quarterly results
Financials & filings
Events & presentations
Stock information
Analyst coverage
Corporate governance
Investor FAQs

Search for:

Press releases

Press releases

Year

Adamas Announces New Employment Inducement Grant

September 11, 2020

Adamas presents new post-hoc data analysis for GOCOVRI® in Parkinson’s disease patients with dyskinesia at the 2020 Movement Disorder Society Virtual Congress

September 11, 2020

Adamas to Present at Upcoming HC Wainwright Conference

September 8, 2020

Adamas Appoints Anna Richo to Board of Directors

September 1, 2020

Adamas Announces New Employment Inducement Grant

August 14, 2020

Adamas Reports Second Quarter 2020 Financial Results

August 6, 2020

Adamas to Announce Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020

July 23, 2020

Adamas presents new post-hoc Phase 3 data analysis for GOCOVRI® in Parkinson’s disease at the 2020 American Academy of Neurology (AAN) Science Highlights Platform

July 15, 2020

Adamas Announces New Employment Inducement Grant

July 10, 2020

Adamas provides program update for ADS-5102 for multiple sclerosis patients with walking impairment

June 17, 2020

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Quick links

Email alerts
Quarterly results

Annual reports
Investor contact

Connect with us

Contact us
Privacy policy
Online tracking opt-out guide
Terms of use
Site map

© 2020 Copyright Adamas Pharmaceuticals, Inc. or its related companies. All rights reserved.

© 2020 Copyright Adamas Pharmaceuticals, Inc. or its related companies. All rights reserved.